5
Table 4. Summary of Recommendations for Monitoring for
ILD Progression
Recommendations
For people with SARDs-ILD, we conditionally recommend monitoring with PFTs.
a
For people with SARDs-ILD, we conditionally recommend monitoring with HRCT chest.
For people with SARDs-ILD, we conditionally recommend monitoring with PFTs and
HRCT chest over PFTs alone.
For people with SARDs-ILD, we conditionally recommend monitoring with
ambulatory desaturation testing.
For people with SARDs-ILD, we conditionally recommend against monitoring with
chest radiography.
For people with SARDs-ILD, we conditionally recommend against monitoring with 6MWD.
For people with SARDs-ILD, we conditionally recommend against monitoring with
bronchoscopy.
For people with IIM-ILD and SSc-ILD, we suggest PFTs for monitoring every 3–6 months
rather than either shorter or longer intervals, for the first year, then less frequently once stable.
For people with RA-ILD, SjD-ILD, and MCTD-ILD, we suggest PFTs for monitoring
every 3–12 months rather than shorter or longer intervals, for the first year, then less
frequently once stable.
For people with SARDs-ILD, we do not provide guidance about frequency of routine
HRCT chest for monitoring ILD but suggest HRCT when clinically indicated.
For people with SARDs-ILD, we suggest assessment for ambulatory desaturation every
3–12 months rather than at shorter or longer intervals.
a
PFTs: Pulmonary function tests including spirometry, lung volumes, and DLCO.
